The application of photosensitisers to tropical pathogens in the blood supply

Photodiagnosis and Photodynamic Therapy

Volumn 8, Issue 3, 2011, Pages 240-248

  Wainwright, Mark ^a   Baptista, Mauricio S ^b  

^a LIVERPOOL JOHN MOORES UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Amotosalen; Blood; Methylene blue; Photosensitiser; Riboflavin; Tropical disease

Indexed keywords

BLOOD SAMPLING; CELL DEATH; DENGUE; ERYTHROCYTE; HEPATITIS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN IMMUNODEFICIENCY VIRUS; LEISHMANIASIS; NONHUMAN; PANDEMIC; PATHOGENESIS; PHOTODYNAMIC THERAPY; PHOTODYNAMICS; PHOTOSENSITIZATION; PRIORITY JOURNAL; REVIEW; TRYPANOSOMA CRUZI; TRYPANOSOMIASIS; VASCULARIZATION; YELLOW FEVER;

BLOOD; BLOOD BANKS; BLOOD PLATELETS; BLOOD TRANSFUSION; BLOOD-BORNE PATHOGENS; COMMUNICABLE DISEASES, EMERGING; DISEASE TRANSMISSION, INFECTIOUS; ERYTHROCYTES; HUMANS; METHYLENE BLUE; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PLASMA; PROTOZOAN INFECTIONS;

TRYPANOSOMA CRUZI;

EID: 84860393563     PISSN: 15721000     EISSN: 18731597     Source Type: Journal    
DOI: 10.1016/j.pdpdt.2011.04.001     Document Type: Review

References (60)

1. Mascarello M., Gobbi F., Angheben A., et al. Imported malaria in immigrants to Italy: a changing pattern observed in north eastern Italy. J Travel Med 2009, 16:317-321.
2. Muñoz J., Gómez i Prat J., Gállego M., et al. Clinical profile of Trypanosoma cruzi infection in a non-endemic setting: immigration and Chagas disease in Barcelona (Spain). Acta Trop 2009, 111:51-55.
3. Grellier P., Santus R., Mouray E., et al. Photosensitized inactivation of Plasmodium falciparum- and Babesia divergens-infected erythrocytes in whole blood by lipophilic pheophorbide derivatives. Vox Sang 1997, 72:211-220.
4. Garraud O. Mechanisms of transfusion-linked parasite infection. Transfus Clin Biol 2006, 13:290-297.
5. Kurtis J.D., Strobl F.J. Other transfusion-transmitted infections. Handbook of transfusion medicine 2001, 301-306. Academic Press, New York. C.D. Hillyer, K.I. Hillyer, F.J. Strobl, L.C. Jefferies, L.E. Silberstein (Eds.).
6. Antonov A. Current relevance of arbovirus infections in transfusion medicine. ISBT Sci Ser 2010, 5:101-106.
7. Blajchman M.A. Protecting the blood supply from emerging pathogens: the role of pathogen inactivation. Transfus Clin Biol 2009, 16:70-74.
8. Zavizion B., Pereira M., de Melo J.M., et al. Inactivation of protozoan parasites in red blood cells using INACTINE PEN110 chemistry. Transfusion (Paris) 2004, 44:731-738.
9. Solheim B.G., Seghatchian J. The six questions of pathogen reduction technology: an overview of current opinions. Transfus Apher Sci 2008, 39:51-57.
10. Wainwright M. Photodynamic antimicrobial chemotherapy (PACT). J Antimicrob Chemother 1998, 42:13-28.
11. Raab O.Z. Uber die wirking fluoreszierender stoffe auf infusorien. Z Biol 1900, 39:524-546.
12. Perdrau J.R., Todd C. The photodynamic action of methylene blue on certain viruses. Proc Roy Soc (Lond) 1932, 112:288-298.
13. T'ung T. Photodynamic action of methylene blue on bacteria. Proc Soc Exp Biol Med 1935, 33:328-330.
14. T'ung T. In vitro photodynamic action of methylene blue on Trypanosoma brucei. Proc Soc Exp Biol Med 1938, 38:29-31.
15. Mohr H., Lambrecht B., Selz A. Photodynamic virus inactivation of blood components. Immunol Invest 1995, 24:73-85.
16. Engelmann F.M., Mayer I., Gabrielli D., Toma H.E., Kowaltowski A.J. Interactions of cationic meso-porphyrins with biomembranes. J Bioenerg Biomembr 2007, 39:175-185.
17. Guttmann P., Ehrlich P. Ueber die wirkung des methylenblau bei malaria. Berlin Klin Woch 1891, 39:953-956.
18. Wainwright M., Crossley K.B. Methylene Blue - a therapeutic dye for all seasons?. J Chemother 2002, 14:431-443.
19. Wainwright M., Mohr H., Walker W. Phenothiazinium derivatives for pathogen inactivation in blood products. J Photochem Photobiol B 2007, 86:45-58.
20. Skripchenko A., Robinette D., Wagner S.J. Comparison of methylene blue and methylene violet for photoinactivation of intracellular and extracellular virus in red cell suspensions. Photochem Photobiol 1997, 65:451-455.
21. Wagner S.J., Skripchenko A., Robinette D., Foley J.W., Cincotta L. Factors affecting virus photoinactivation by a series of phenothiazine dyes. Photochem Photobiol 1998, 67:343-349.
22. Wainwright M., Phoenix D.A., Rice L., Burrow S.M., Waring J.J. Increased cytotoxicity and phototoxicity in the methylene blue series via chromophore methylation. J Photochem Photobiol B 1997, 40:233-239.
23. Van Steveninck J., Trannoy L.L., Besselink G.A., et al. Selective protection of RBCs against photodynamic damage by the band 3 ligand dipyramidole. Transfusion (Paris) 2000, 40:1330-1336.
24. Besselink G.A., van Engelenburg F.A., Ebbing I.G., Hilarius P.M., de Korte D., Verhoeven A.J. Additive effects of dipyramidole and Trolox in protecting human red cells during photodynamic treatment. Vox Sang 2003, 85:25-30.
25. Schultz E.W., Krueger A.P. Inactivation of Staphylococcus bacteriophage by methylene blue. Proc Soc Exp Biol Med 1928, 26:100-101.
26. Seghatchian J., Walker W.H., Reichenberg S. Updates on pathogen inactivation of plasma using Theraflex methylene blue system. Transfus Apher Sci 2008, 38:271-280.
27. Papin J.F., Floyd R.A., Dittmer D.P. Methylene blue photoinactivation abolishes West Nile virus infectivity in vivo. Antiviral Res 2005, 68:84-87.
28. Huang Q., Fu W.L., Chen B., Huang J.F., Zhang X., Xue Q. Inactivation of dengue virus by methylene blue/narrow bandwidth light system. J Photochem Photobiol B 2004, 77:39-43.
29. Findlay G.M. Immunization against yellow fever. Trans R Soc Trop Med Hyg 1934, 27:437-469.
30. Gironés N., Bueno B.L., Carrión J., Fresno M., Castro E. The efficacy of photochemical treatment with methylene blue and light for the reduction of Trypanosoma cruzi in infected plasma. Vox Sang 2006, 91:285-291.
31. Mauel J. Intracellular parasite killing induced by electron carriers I. Effect of electron carriers on intracellular Leishmania spp. in macrophages from different genetic backgrounds. Mol Biochem Parasitol 1984, 13:83-96.
32. Rounds D.E., Opel W., Olson R.S. The potential use of laser energy in the management of malaria. Biochem Biophys Res Commun 1968, 32:616-623.
33. Vennerstrom J.L., Makler M.T., Angerhofer C.K., Williams J.A. Antimalarial dyes revisited: xanthenes, azines, oxazines and thiazines. Antimicrob Agents Chemother 1995, 39:2671-2677.
34. Bountogo M., Zoungrana A., Coulibaly B., et al. Efficacy of methylene blue monotherapy in semi-immune adults with uncomplicated falciparum malaria: a controlled trial in Burkina Faso. Trop Med Int Health 2010, 15:713-717.
35. Rampersad J., Cesar E., Campbell M.D., Samlal M., Ammons D. A field evaluation of PCR for the routine detection of Babesia equi in horses. Vet Parasitol 2003, 114:81-87.
36. Wainwright M. Ring-fused derivatives of 3,7-diaminophenothiazinium and phenoselenazinium salts for use as antimicrobial agents. GB Pat 2 2009, 453:564.
37. Goodrich R.P., Edrich R.A., Li J., Seghatchian J. The Mirasol™ PRT system for pathogen reduction of platelets and plasma: an overview of current status and future trends. Transfus Apher Sci 2006, 35:5-17.
38. Reddy H.L., Dayan A.D., Cavagnaro J., Gad S., Li J., Goodrich R.P. Toxicity testing of a novel riboflavin-based technology for pathogen reduction and white blood cell inactivation. Transfus Med Rev 2008, 22:133-153.
39. Hardwick C.C., Herivel T.R., Hernandez S.C., Ruane P.H., Goodrich R.P. Separation, identification and quantification of riboflavin and its photoproducts in blood products using HLPC with fluorescence detection: a method to support pathogen-reduction technology. Photochem Photobiol 2004, 80:609-615.
40. Seghatchian J., de Sousa G. Pathogen-reduction systems for blood components: the current position and future trends. Transfus Apher Sci 2006, 35:189-196.
41. Dardare N., Platz M.S. Binding affinities of commonly employed sanitizers of viral inactivation. Photochem Photobiol 2002, 75:561-564.
42. Cardo L.J., Rentas F.J., Ketchum L., et al. Pathogen inactivation of Leishmania donovani infantum in plasma and platelet concentrates using riboflavin and ultraviolet light. Vox Sang 2006, 90:85-91.
43. Cardo L.J., Salata J., Mendez J., Reddy H., Goodrich R. Pathogen inactivation of Trypanosoma cruzi in plasma and platelet concentrates using riboflavin and ultraviolet light. Transfus Apher Sci 2007, 37:131-137.
44. Reddy H., Goodrich R.P. Inactivation of West Nile virus and malaria using photosensitizers. Vox Sang 2003, WO 2003063902.
45. Docampo R., Moreno S.N., Gadelha F.R., de Souza W., Cruz F.S. Prevention of Chagas' disease resulting from blood transfusion by treatment of blood: toxicity and mode of action of gentian violet. Biomed Environ Sci 1988, 1:406-413.
46. Wendel S. Transfusion transmitted Chagas' disease: is it really under control?. Acta Trop 2010, 115:28-34.
47. Ramirez L.E., Lages-Silva E., Pianetti G.M., Rabelo R.M.C., Bordin J.O., Moraes-Souza H. Prevention of transfusion-associated Chagas' disease by sterilization of Trypanosoma cruzi-infected blood with gentian violet, ascorbic acid and light. Transfusion (Paris) 1995, 35:226-230.
48. Gottlieb P., Shen L.G., Chimezie E., et al. Inactivation of Trypanosoma cruzi trypomastigote forms in blood components by photodynamic treatment with phthalocyanines. Photochem Photobiol 1995, 62:869-874.
49. Lustigman S., Ben-Hur E. Photosensitized inactivation of Plasmodium falciparum in human red cells by phthalocyanines. Transfusion (Paris) 1996, 36:543-546.
50. Trannoy L.L., Terpstra F.G., de Korte D., et al. Differential sensitivities of pathogens in red cell concentrates to Tri-P(4)-photoinactivation. Vox Sang 2006, 91:111-118.
51. Zupan K., Egyeki M., Toth K., et al. Comparison of the efficiency and the specificity of DNA-bound and free cationic porphyrin in photodynamic virus inactivation. J Photochem Photobiol B 2008, 90:105-112.
52. Corash L. Inactivation of viruses, bacteria, protozoa and platelet concentrates: current research perspective. Transfus Med Rev 1999, 13:18-30.
53. McClaskey J., Xu M., Snyder E.L., Tormey C.A. Clinical trials for pathogen reduction in transfusion medicine: a review. Transfus Apher Sci 2009, 41:217-225.
54. Castro E., Gironés N., Bueno J.L., Carrión J., Lin L., Fresno M. The efficacy of photochemical treatment with amotosalen HCl and ultraviolet A (INTERCEPT) for inactivation of Trypanosoma cruzi in pooled buffy-coat platelets. Transfusion (Paris) 2007, 47:434-441.
55. McCullough J., Vesole D.H., Benjamin R.J., et al. Therapeutic efficacy and safety of platelets treated with a photochemical process for pathogen inactivation: the SPRINT trial. Blood 2004, 104:1534-1541.
56. Petersen L.R., Stramer S.L., Powers A.M. Chikungunya virus: possible impact on transfusion medicine. Transfus Med Rev 2010, 24:15-21.
57. Wagner S.J., Robinette D., Storry J., Chen X.Y., Shumaker J., Benade L. Differential sensitivities of viruses in red cell suspensions to methylene blue photosensitization. Transfusion (Paris) 1994, 34:521-526.
58. Prowse C. Properties of pathogen-inactivated plasma components. Transfus Med Rev 2009, 23:124-133.
59. Wagner S.J., Skripchenko A., Donnelly D.J., Ramaswamy K., Detty M.R. Chalogenoxanthylium photosensitizers for the photodynamic purging of blood-borne viral and bacterial pathogens. Bioorg Med Chem 2005, 13:5927-5935.
60. Wagner S.J., Skripchenko A., Salata J., O'Sullivan A.M., Cardo L.J. Inactivation of Leishmania donovani infantum and Trypanosoma cruzi in red cell suspensions with thiazole orange. Transfusion (Paris) 2008, 48:1363-1367.